nodes	percent_of_prediction	percent_of_DWPC	metapath
Arbutamine—Masoprocol—IGF1R—breast cancer	0.0375	0.27	CrCbGaD
Arbutamine—Dobutamine—COMT—breast cancer	0.0168	0.121	CrCbGaD
Arbutamine—Mirabegron—BCHE—breast cancer	0.0138	0.0991	CrCbGaD
Arbutamine—Masoprocol—CYP19A1—breast cancer	0.0119	0.0854	CrCbGaD
Arbutamine—Mirabegron—CYP2D6—breast cancer	0.00756	0.0544	CrCbGaD
Arbutamine—Mirabegron—CYP3A4—breast cancer	0.00648	0.0467	CrCbGaD
Arbutamine—Arformoterol—CYP2D6—breast cancer	0.00604	0.0435	CrCbGaD
Arbutamine—Formoterol—CYP2D6—breast cancer	0.00604	0.0435	CrCbGaD
Arbutamine—Salmeterol—CYP3A4—breast cancer	0.00593	0.0427	CrCbGaD
Arbutamine—Mirabegron—ALB—breast cancer	0.00565	0.0407	CrCbGaD
Arbutamine—Mirabegron—ABCB1—breast cancer	0.0054	0.0388	CrCbGaD
Arbutamine—Epinephrine—TNF—breast cancer	0.00483	0.0347	CrCbGaD
Arbutamine—Labetalol—CYP2D6—breast cancer	0.00441	0.0318	CrCbGaD
Arbutamine—Isoprenaline—CYP1A1—breast cancer	0.00437	0.0314	CrCbGaD
Arbutamine—Epinephrine—CYP3A4—breast cancer	0.00234	0.0169	CrCbGaD
Arbutamine—ADRB2—Signaling Pathways—CXCL12—breast cancer	0.000299	0.000347	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—NOTCH1—breast cancer	0.000296	0.000344	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TCF7L2—breast cancer	0.000294	0.000342	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PAK1—breast cancer	0.000293	0.00034	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—AKT2—breast cancer	0.000293	0.00034	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—PIK3CG—breast cancer	0.000291	0.000338	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PIK3CG—breast cancer	0.000289	0.000336	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—KIT—breast cancer	0.000289	0.000336	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—APC—breast cancer	0.000289	0.000336	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TCF7L2—breast cancer	0.000288	0.000334	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—AKT2—breast cancer	0.000287	0.000333	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—EGF—breast cancer	0.000286	0.000332	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—PIK3CG—breast cancer	0.000284	0.00033	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NOTCH2—breast cancer	0.000284	0.000329	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—HSP90AA1—breast cancer	0.000284	0.000329	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—PIK3CD—breast cancer	0.000281	0.000327	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NOTCH2—breast cancer	0.000278	0.000322	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—HSP90AA1—breast cancer	0.000278	0.000322	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—MAPK3—breast cancer	0.000277	0.000322	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PRL—breast cancer	0.000276	0.000321	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—AGTR1—breast cancer	0.000276	0.000321	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—PIK3CD—breast cancer	0.000275	0.00032	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—STK11—breast cancer	0.000272	0.000316	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ADAM10—breast cancer	0.000272	0.000316	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—BRAF—breast cancer	0.000272	0.000316	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—AGTR1—breast cancer	0.00027	0.000314	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PRL—breast cancer	0.00027	0.000314	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PLG—breast cancer	0.000269	0.000312	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—STK11—breast cancer	0.000266	0.000309	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ADAM10—breast cancer	0.000266	0.000309	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—AKT2—breast cancer	0.000266	0.000309	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—IGF1—breast cancer	0.000265	0.000308	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—AKT2—breast cancer	0.000265	0.000307	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—FGF10—breast cancer	0.000265	0.000307	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—EGFR—breast cancer	0.000264	0.000306	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PLG—breast cancer	0.000263	0.000306	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—AKT2—breast cancer	0.00026	0.000302	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FGF10—breast cancer	0.000259	0.000301	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—PIK3CD—breast cancer	0.000256	0.000297	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PDGFA—breast cancer	0.000255	0.000297	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PIK3CD—breast cancer	0.000254	0.000295	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—PIK3CA—breast cancer	0.000252	0.000293	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TGFBR2—breast cancer	0.000252	0.000292	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—SERPINE1—breast cancer	0.000252	0.000292	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—PIK3CD—breast cancer	0.00025	0.00029	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PDGFA—breast cancer	0.00025	0.00029	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—KRAS—breast cancer	0.000249	0.000289	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ITPR1—breast cancer	0.000248	0.000288	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TGFBR2—breast cancer	0.000246	0.000286	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ERBB4—breast cancer	0.000246	0.000286	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MMP3—breast cancer	0.000246	0.000286	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—STAT5A—breast cancer	0.000246	0.000286	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—PIK3CB—breast cancer	0.000245	0.000285	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ITPR1—breast cancer	0.000242	0.000281	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MMP3—breast cancer	0.000241	0.000279	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—STAT5A—breast cancer	0.000241	0.000279	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ERBB4—breast cancer	0.000241	0.000279	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—NOS3—breast cancer	0.00024	0.000279	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—PIK3CB—breast cancer	0.00024	0.000279	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—SMAD4—breast cancer	0.000238	0.000277	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—IGF1R—breast cancer	0.000237	0.000275	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—CXCL8—breast cancer	0.000236	0.000274	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—SMAD4—breast cancer	0.000233	0.000271	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—HES1—breast cancer	0.000233	0.00027	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—IGF1R—breast cancer	0.000232	0.000269	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NCOR1—breast cancer	0.000231	0.000269	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PLA2G4A—breast cancer	0.000231	0.000269	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—CXCL8—breast cancer	0.000231	0.000268	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—PIK3CA—breast cancer	0.000229	0.000266	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CSF2—breast cancer	0.000229	0.000266	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—FGF1—breast cancer	0.000229	0.000266	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—RAF1—breast cancer	0.000228	0.000265	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—MDM2—breast cancer	0.000228	0.000265	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—HES1—breast cancer	0.000228	0.000264	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—RAF1—breast cancer	0.000227	0.000264	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NRG1—breast cancer	0.000227	0.000264	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NCOR1—breast cancer	0.000226	0.000263	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PLA2G4A—breast cancer	0.000226	0.000263	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—RELA—breast cancer	0.000226	0.000263	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—H2AFX—breast cancer	0.000225	0.000262	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—IL2—breast cancer	0.000225	0.000262	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—ERBB2—breast cancer	0.000225	0.000261	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—E2F1—breast cancer	0.000224	0.00026	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CSF2—breast cancer	0.000224	0.00026	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FGF1—breast cancer	0.000224	0.00026	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—RAF1—breast cancer	0.000223	0.000259	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—PIK3CB—breast cancer	0.000223	0.000259	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NRG1—breast cancer	0.000222	0.000258	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—MTOR—breast cancer	0.000222	0.000257	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PIK3CB—breast cancer	0.000222	0.000257	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—H2AFX—breast cancer	0.00022	0.000256	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—IL2—breast cancer	0.00022	0.000256	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—E2F1—breast cancer	0.000219	0.000254	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—PIK3CB—breast cancer	0.000218	0.000253	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—SPP1—breast cancer	0.000215	0.00025	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—CXCL8—breast cancer	0.000214	0.000249	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CXCL8—breast cancer	0.000213	0.000247	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ERBB3—breast cancer	0.000213	0.000247	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—FGFR2—breast cancer	0.000212	0.000247	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—HRAS—breast cancer	0.000212	0.000246	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—SPP1—breast cancer	0.00021	0.000244	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—CXCL8—breast cancer	0.000209	0.000243	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CDKN1B—breast cancer	0.000208	0.000242	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ERBB3—breast cancer	0.000208	0.000242	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FGFR2—breast cancer	0.000208	0.000241	CbGpPWpGaD
Arbutamine—ADRB3—GPCR downstream signaling—AKT1—breast cancer	0.000206	0.000239	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—IL2—breast cancer	0.000205	0.000238	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CASP3—breast cancer	0.000204	0.000237	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TERT—breast cancer	0.000204	0.000237	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—IL2—breast cancer	0.000204	0.000236	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—IL6—breast cancer	0.000203	0.000235	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—IL2—breast cancer	0.0002	0.000232	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TERT—breast cancer	0.000199	0.000232	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CCND1—breast cancer	0.000198	0.000231	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—JUN—breast cancer	0.000198	0.00023	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—FGFR1—breast cancer	0.000198	0.00023	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CTNNB1—breast cancer	0.000197	0.000228	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—HIF1A—breast cancer	0.000195	0.000226	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FGFR1—breast cancer	0.000194	0.000225	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—MMP9—breast cancer	0.000193	0.000224	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—CDKN1A—breast cancer	0.000192	0.000223	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PTEN—breast cancer	0.000192	0.000222	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—HIF1A—breast cancer	0.000191	0.000221	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—LEP—breast cancer	0.00019	0.000221	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CAV1—breast cancer	0.000189	0.000219	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—MAPK8—breast cancer	0.000187	0.000218	CbGpPWpGaD
Arbutamine—ADRB3—Signaling by GPCR—AKT1—breast cancer	0.000187	0.000217	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—KDR—breast cancer	0.000186	0.000216	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—LEP—breast cancer	0.000186	0.000216	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CAV1—breast cancer	0.000184	0.000214	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—KDR—breast cancer	0.000182	0.000212	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ESR1—breast cancer	0.000182	0.000211	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—FN1—breast cancer	0.000179	0.000208	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ESR1—breast cancer	0.000178	0.000206	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—SRC—breast cancer	0.000178	0.000206	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NFKBIA—breast cancer	0.000177	0.000206	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NOTCH1—breast cancer	0.000176	0.000204	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—FN1—breast cancer	0.000176	0.000204	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NFKBIA—breast cancer	0.000173	0.000201	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—VEGFA—breast cancer	0.000173	0.000201	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NOTCH1—breast cancer	0.000172	0.000199	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PIK3CG—breast cancer	0.000172	0.000199	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—KIT—breast cancer	0.000172	0.000199	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—APC—breast cancer	0.000172	0.000199	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—STAT3—breast cancer	0.000171	0.000199	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—EGF—breast cancer	0.00017	0.000197	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PIK3CG—breast cancer	0.000168	0.000195	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—APC—breast cancer	0.000168	0.000195	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—KIT—breast cancer	0.000168	0.000195	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—EGF—breast cancer	0.000166	0.000193	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—MAPK3—breast cancer	0.000164	0.000191	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—MAPK3—breast cancer	0.000164	0.00019	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—BRAF—breast cancer	0.000161	0.000187	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—MAPK3—breast cancer	0.000161	0.000187	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—MYC—breast cancer	0.000159	0.000185	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—TGFB1—breast cancer	0.000159	0.000184	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—BRAF—breast cancer	0.000158	0.000183	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—IGF1—breast cancer	0.000157	0.000183	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—AKT2—breast cancer	0.000157	0.000182	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—EGFR—breast cancer	0.000156	0.000182	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—EGFR—breast cancer	0.000156	0.000181	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—IGF1—breast cancer	0.000154	0.000179	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—AKT2—breast cancer	0.000154	0.000178	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—EGFR—breast cancer	0.000153	0.000178	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PIK3CD—breast cancer	0.000151	0.000175	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	0.00015	0.000174	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—SERPINE1—breast cancer	0.000149	0.000173	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—KRAS—breast cancer	0.000148	0.000172	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PIK3CD—breast cancer	0.000148	0.000172	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—KRAS—breast cancer	0.000147	0.000171	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	0.000146	0.00017	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—SERPINE1—breast cancer	0.000146	0.00017	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—KRAS—breast cancer	0.000145	0.000168	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—NOS3—breast cancer	0.000143	0.000166	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—NOS3—breast cancer	0.000139	0.000162	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	0.000136	0.000158	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MDM2—breast cancer	0.000135	0.000157	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—PIK3CA—breast cancer	0.000135	0.000157	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—RAF1—breast cancer	0.000135	0.000157	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—RELA—breast cancer	0.000134	0.000156	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—ERBB2—breast cancer	0.000133	0.000155	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	0.000133	0.000154	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MDM2—breast cancer	0.000132	0.000154	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—RAF1—breast cancer	0.000132	0.000153	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PIK3CB—breast cancer	0.000132	0.000153	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MTOR—breast cancer	0.000132	0.000153	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—RELA—breast cancer	0.000131	0.000152	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—TP53—breast cancer	0.000131	0.000152	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—ERBB2—breast cancer	0.00013	0.000151	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PIK3CB—breast cancer	0.000129	0.000149	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MTOR—breast cancer	0.000129	0.000149	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CXCL8—breast cancer	0.000126	0.000147	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—HRAS—breast cancer	0.000126	0.000146	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—HRAS—breast cancer	0.000125	0.000145	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CXCL8—breast cancer	0.000124	0.000144	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CDKN1B—breast cancer	0.000123	0.000143	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—HRAS—breast cancer	0.000123	0.000143	CbGpPWpGaD
Arbutamine—ADRB1—GPCR downstream signaling—AKT1—breast cancer	0.000122	0.000142	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CASP3—breast cancer	0.000121	0.000141	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—IL2—breast cancer	0.000121	0.00014	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CDKN1B—breast cancer	0.000121	0.00014	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—IL6—breast cancer	0.00012	0.00014	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—IL6—breast cancer	0.00012	0.000139	CbGpPWpGaD
Arbutamine—ADRB2—GPCR downstream signaling—AKT1—breast cancer	0.000119	0.000139	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CASP3—breast cancer	0.000118	0.000137	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—IL2—breast cancer	0.000118	0.000137	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CCND1—breast cancer	0.000118	0.000137	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—IL6—breast cancer	0.000118	0.000137	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—JUN—breast cancer	0.000118	0.000137	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CTNNB1—breast cancer	0.000117	0.000135	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CCND1—breast cancer	0.000115	0.000134	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—JUN—breast cancer	0.000115	0.000134	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MMP9—breast cancer	0.000114	0.000133	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CTNNB1—breast cancer	0.000114	0.000133	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—CDKN1A—breast cancer	0.000114	0.000132	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PTEN—breast cancer	0.000114	0.000132	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MMP9—breast cancer	0.000112	0.00013	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—CDKN1A—breast cancer	0.000111	0.000129	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MAPK8—breast cancer	0.000111	0.000129	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PTEN—breast cancer	0.000111	0.000129	CbGpPWpGaD
Arbutamine—ADRB1—Signaling by GPCR—AKT1—breast cancer	0.000111	0.000129	CbGpPWpGaD
Arbutamine—ADRB3—Signaling Pathways—AKT1—breast cancer	0.00011	0.000128	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MAPK8—breast cancer	0.000109	0.000126	CbGpPWpGaD
Arbutamine—ADRB2—Signaling by GPCR—AKT1—breast cancer	0.000109	0.000126	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—SRC—breast cancer	0.000105	0.000122	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—SRC—breast cancer	0.000103	0.00012	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—VEGFA—breast cancer	0.000103	0.000119	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—STAT3—breast cancer	0.000102	0.000118	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—VEGFA—breast cancer	0.0001	0.000117	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—STAT3—breast cancer	9.95e-05	0.000116	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MAPK3—breast cancer	9.72e-05	0.000113	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MAPK3—breast cancer	9.5e-05	0.00011	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—MYC—breast cancer	9.45e-05	0.00011	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TGFB1—breast cancer	9.43e-05	0.000109	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—MYC—breast cancer	9.24e-05	0.000107	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—EGFR—breast cancer	9.24e-05	0.000107	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TGFB1—breast cancer	9.22e-05	0.000107	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—EGFR—breast cancer	9.04e-05	0.000105	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—KRAS—breast cancer	8.73e-05	0.000101	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—KRAS—breast cancer	8.54e-05	9.92e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—PIK3CA—breast cancer	8.02e-05	9.32e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—PIK3CA—breast cancer	7.85e-05	9.11e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—TP53—breast cancer	7.76e-05	9.01e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—TP53—breast cancer	7.59e-05	8.82e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—HRAS—breast cancer	7.42e-05	8.62e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—HRAS—breast cancer	7.26e-05	8.43e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—IL6—breast cancer	7.1e-05	8.25e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—IL6—breast cancer	6.95e-05	8.07e-05	CbGpPWpGaD
Arbutamine—ADRB1—Signaling Pathways—AKT1—breast cancer	6.55e-05	7.61e-05	CbGpPWpGaD
Arbutamine—ADRB2—Signaling Pathways—AKT1—breast cancer	6.41e-05	7.44e-05	CbGpPWpGaD
